Rolf Jautelat is heading the R&D Product Owner Hub, part of the R&D Data Science & AI unit of Bayer Pharmaceuticals. There, he is involved in organizing the digital landscape and driving the digital transformation for R&D Pharmaceuticals. Previously, he was ingrained in the Medicinal Chemistry unit at Bayer Pharmaceuticals, where he pursued over 20 years of research with drug discovery projects aiming for cardiovascular drugs, targeted anti-cancer agents, antibody-drug conjugates and new ophthalmic agents. He is a co-inventor of the approved drug Verquvo. Rolf received a Ph.D. in synthetic chemistry from the University of Hannover followed by postdoctoral studies at the Scripps Research Institute, La Jolla. https://de.linkedin.com/in/rolf-jautelat